PC
MITO

PA Capital’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

PA Capital’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$23K Sell
16,773
-4,615
-22% -$7.9K 0.02% 173
2020
Q2 		$39K Sell
21,388
-1,073
-5% -$1.96K 0.03% 165
2020
Q1 		$28K Buy
+22,461
New +$49.9K 0.02% 162

Other funds holding MITO

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

PA Capital's MITO Position: Q3 2020 in Review

PA Capital reduced its Stealth BioTherapeutics Corp. ADS (MITO) stake by 22% in Q3 2020, selling an estimated $7.9K and leaving 16,773 shares worth $23K. The position accounts for 0.02% of the portfolio, ranked #173.

PA Capital first reported a position in MITO in Q1 2020 and has held it in 3 quarters since. The position peaked at $39K in Q2 2020. 10 funds tracked by Wall St. Rank hold MITO as of Q3 2020.

  • PA Capital held 16,773 shares of Stealth BioTherapeutics Corp. ADS worth $23K as of Q3 2020.
  • PA Capital sold 4,615 Stealth BioTherapeutics Corp. ADS shares in Q3 2020, an estimated $7.9K.
  • Stealth BioTherapeutics Corp. ADS made up 0.02% of PA Capital's portfolio in Q3 2020, its #173 holding.
  • PA Capital first reported a position in Stealth BioTherapeutics Corp. ADS in Q1 2020 and has held it in 3 quarters since.
  • PA Capital's Stealth BioTherapeutics Corp. ADS position peaked at $39K in Q2 2020.
  • 10 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q3 2020.

Based on PA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.